Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.414 USD | -0.24% | +2.02% | -45.32% |
25/04 | Soligenix Extends Patent Protection for Its Filovirus Vaccine Platform to the United Kingdom and South Africa | CI |
15/04 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Sales 2024 * | 800K 66.81M | Sales 2025 * | 900K 75.16M | Capitalization | 5.9M 492M |
---|---|---|---|---|---|
Net income 2024 * | -8M -668M | Net income 2025 * | -9M -752M | EV / Sales 2024 * | 7.37 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.55 x |
P/E ratio 2024 * |
-0.66
x | P/E ratio 2025 * |
-0.73
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.93% |
1 day | -0.24% | ||
1 week | +2.02% | ||
Current month | -31.00% | ||
1 month | -31.00% | ||
3 months | -35.31% | ||
6 months | -15.84% | ||
Current year | -45.32% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 01/06/01 | |
Jonathan Guarino
DFI | Director of Finance/CFO | 51 | 11/19/11 |
Richard Straube
CTO | Chief Tech/Sci/R&D Officer | 72 | 06/14/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 01/06/01 | |
Gregg Lapointe
BRD | Director/Board Member | 65 | 01/09/01 |
Robert Rubin
BRD | Director/Board Member | 78 | 01/09/01 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 0.414 | -0.24% | 120,404 |
26/24/26 | 0.415 | -2.81% | 269,354 |
25/24/25 | 0.427 | +11.49% | 684,696 |
24/24/24 | 0.383 | -4.25% | 497,507 |
23/24/23 | 0.4 | -1.43% | 448,982 |
Delayed Quote Nasdaq, April 30, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.32% | 5.9M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.46% | 22.18B | |
-16.67% | 21.2B | |
-8.58% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- SNGX Stock